Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0001193125-22-134370
Filing Date
2022-04-29
Accepted
2022-04-29 17:26:22
Documents
16
Period of Report
2021-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K/A d353074d10ka.htm   iXBRL 10-K/A 497394
2 EX-31.3 d353074dex313.htm EX-31.3 3582
3 EX-31.4 d353074dex314.htm EX-31.4 3537
  Complete submission text file 0001193125-22-134370.txt   761567

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA srra-20211231.xsd EX-101.SCH 4697
5 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE srra-20211231_cal.xml EX-101.CAL 685
6 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE srra-20211231_def.xml EX-101.DEF 1690
7 XBRL TAXONOMY EXTENSION LABEL LINKBASE srra-20211231_lab.xml EX-101.LAB 28451
8 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE srra-20211231_pre.xml EX-101.PRE 17717
10 EXTRACTED XBRL INSTANCE DOCUMENT d353074d10ka_htm.xml XML 7573
Mailing Address 1820 GATEWAY DRIVE SUITE 110 SAN MATEO CA 94404
Business Address 1820 GATEWAY DRIVE SUITE 110 SAN MATEO CA 94404 (605) 376-8679
Sierra Oncology, Inc. (Filer) CIK: 0001290149 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K/A | Act: 34 | File No.: 001-37490 | Film No.: 22877776
SIC: 2834 Pharmaceutical Preparations